In the past, clinical trials have been conducted by centralized research organizations. In recent years, though, there has been a shift toward conducting clinical trials decentralized, which means that the trials are being conducted by multiple sites.
This is often referred to as a distributed clinical trial design, and it allows for more efficient use of resources. In this post, we’ll cover the benefits of a distributed clinical trial design and provide some decentralized clinical trials guidance.
What are decentralized clinical trials
Decentralized clinical trials moved away from the now outdated centralized clinical trials. The trials are now carried out on different sites.
The decentralized trials are defined as trials centered around the patient’s needs. The trial activities are brought to the patient rather than the other way round, where the patient is brought to the clinical facility. The traditional way which is now being phased out is the centralized system.
Benefits of decentralized clinical trials
Decentralized clinical trials focus on patient satisfaction because it brings the facilities to the patient rather than going to the facility. The move makes the patient feel comfortable instead of feeling like a caged lab rat.
Decentralized trials reduce the need to travel to study sites. The patients end up saving on time and money because there is no need to travel.
The decentralized clinical trials are far more efficient in delivering medical findings than the traditional method. The traditional method was inefficient because of the use of selected populations, which limited the outcome of the results.
The decentralized system has decreased dropout rates from participants making it the go-to system when implementing medical trials.
Benefits of decentralized clinical trials for patients
Patients get more regular tests than the traditional method. More tests mean the patient is more confident they will get positive feedback from their doctors.
Patients have a personal research nurse who is tasked to monitor their physical well-being. Having a personal nurse gives the patient reassurance that someone is looking out for their needs.
There are improved data and privacy measures in place in a decentralized system. The patient’s data is secure, and they can be assured when undergoing medical trials.
The system is more engaging because of the digital involvement in the trials. It gives patients more engagement with the doctors and improves the communication lines between them.
Are decentralized trials here to stay
Yes, the decentralized trials are here to stay. The centralized trials had a burden on the patients and the family caregivers. The costs of transportation and welfare of the patient created so many hurdles for the researchers and the patient.
The pandemic gave the centralized system a reality check, and the enrolment into the traditional set-up proved more difficult. The decentralized system offered an alternative means of study participation.
Without proper infrastructure in place, decentralized designs will be difficult to achieve. Due to recent times, sponsors have flooded the medical field to assist in creating an environment that will be conducive for all patients.
Decentralized trials are here to stay because the COVID-19 shaped the medical research environment. The need to keep distance from infected people prompted this switch. Doctors can now visit patients virtually by use of electronic information to deliver health care at a distance.
The future of decentralized clinical studies
The future of decentralized trials depends on the structures put in place to implement in other studies. The COVID-19 pandemic developed a structure that other trials can implement to battle other diseases. Oncology trials can benefit from these structures to improve patient care and find a cure for cancer.
The guidance from the FDA will shape trials in the future and help create a design that is satisfactory to the patients and the sponsors of these trials.
The future of medical trials is all about overcoming challenges and identifying opportunities that will play a crucial role in creating a world free of fatal diseases.
Decentralized Clinical Trials Guidance Final thoughts
The COVID-19 pandemic accelerated the switch to decentralized trials, and the move has been received with open arms because of its more patient-centric approach. Sponsors and health care providers have lauded the switch, and they have requested more models to adopt the approach. The shift has happened, and it will continue shaping the industry for years to come.
Rhonda Evans is a writer for Key Business Profiles, a platform dedicated to capturing the evolving landscape of UK businesses. With a keen eye for detail and a passion for economic and social trends, Rhonda crafts insightful content that reflects the voices of business owners, managers, and entrepreneurs across various industries.
